Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-lian Hu

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
World Journal of Gastroenterology|May 12, 2010
Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strainsLi-Hui Wang, Hong Cheng, Fu-Lian Hu, et al.
Zhonghua Yi Xue Za Zhi|December 4, 2009
[Genotypic homogeneity and susceptibility to clarithromycin for clarithromycin-resistant Helicobacter pylori strains]Xiao-Li Zheng, Fu-Lian Hu, Wei-Hong Wang, et al.
Zhonghua Yi Xue Za Zhi|October 30, 2008
[Establishment of Mongolian gerbil model of long-term Helicobacter pylori infection]Zhe Jin, Fu-Lian Hu, Hong Wei, et al.
Zhonghua Yi Xue Za Zhi|June 19, 2003
[A study on the relationship of Helicobacter pylori, gastrin and gastroesophageal reflux disease]Gui-jian Feng, Fu-lian Hu, Hua-hong Wang, et al.
Zhonghua Yi Xue Za Zhi|February 23, 2007
[Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer]Rui-fang Guo, Shi-zhu Zang, Liang Zhang, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|September 4, 2009
[Identification of biomarkers for early detection in gastric cancer and its clinical biological significance.]Rui-fang Guo, Shi-zhu Zang, Jing-yuan Fang, et al.
Zhonghua Yi Xue Za Zhi|April 2, 2010
[Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study]Hong Cheng, Fu-lian Hu, Guo-xin Zhang, et al.
Zhonghua Yi Xue Za Zhi|February 14, 2014
[Jinghuaweikang gelatin pearls plus proton pump inhibitor-based triple regimen in the treatment of chronic atrophic gastritis with Helicobacter pylori infection: a multicenter, randomized, controlled clinical study]Ting-ting Wang, Yue-miao Zhang, Xue-zhi Zhang, et al.
Zhonghua Yi Xue Za Zhi|November 20, 2012
[Ilaprazole based bismuth-containing quadruple regimen for the first-line treatment of Helicobacter pylori infection: a multicenter, randomized, controlled clinical study]Wen Gao, Hong Cheng, Fu-lian Hu, et al.
Zhonghua Yi Xue Za Zhi|July 12, 2012
[Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study]Fu-lian Hu, Hong Cheng, Xue-zhi Zhang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
World Journal of Gastroenterology|May 12, 2010
Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strainsLi-Hui Wang, Hong Cheng, Fu-Lian Hu, et al.
Zhonghua Yi Xue Za Zhi|December 4, 2009
[Genotypic homogeneity and susceptibility to clarithromycin for clarithromycin-resistant Helicobacter pylori strains]Xiao-Li Zheng, Fu-Lian Hu, Wei-Hong Wang, et al.
Zhonghua Yi Xue Za Zhi|October 30, 2008
[Establishment of Mongolian gerbil model of long-term Helicobacter pylori infection]Zhe Jin, Fu-Lian Hu, Hong Wei, et al.
Zhonghua Yi Xue Za Zhi|June 19, 2003
[A study on the relationship of Helicobacter pylori, gastrin and gastroesophageal reflux disease]Gui-jian Feng, Fu-lian Hu, Hua-hong Wang, et al.
Zhonghua Yi Xue Za Zhi|February 23, 2007
[Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer]Rui-fang Guo, Shi-zhu Zang, Liang Zhang, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|September 4, 2009
[Identification of biomarkers for early detection in gastric cancer and its clinical biological significance.]Rui-fang Guo, Shi-zhu Zang, Jing-yuan Fang, et al.
Zhonghua Yi Xue Za Zhi|April 2, 2010
[Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study]Hong Cheng, Fu-lian Hu, Guo-xin Zhang, et al.
Zhonghua Yi Xue Za Zhi|February 14, 2014
[Jinghuaweikang gelatin pearls plus proton pump inhibitor-based triple regimen in the treatment of chronic atrophic gastritis with Helicobacter pylori infection: a multicenter, randomized, controlled clinical study]Ting-ting Wang, Yue-miao Zhang, Xue-zhi Zhang, et al.
Zhonghua Yi Xue Za Zhi|November 20, 2012
[Ilaprazole based bismuth-containing quadruple regimen for the first-line treatment of Helicobacter pylori infection: a multicenter, randomized, controlled clinical study]Wen Gao, Hong Cheng, Fu-lian Hu, et al.
Zhonghua Yi Xue Za Zhi|July 12, 2012
[Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study]Fu-lian Hu, Hong Cheng, Xue-zhi Zhang, et al.
Pageof 3